CTOs on the Move


 
Medwatch is a Lake Mary, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.urmedwatch.com
  • 120 International Pkwy Ste 216
    Lake Mary, FL USA 32746
  • Phone: 800.432.8421

Executives

Name Title Contact Details

Similar Companies

Contract Research Organization

WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.

Spray-Tek

Spray-Tek is a Middlesex, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alquest

Alquest has supported numerous international trials and registrations for device clients. Alquest's consulting staff comes from the medical device industry. We've been there. More than half our clients return to us for repeat business. Several device

Reach Fitness Club

Reach Fitness Club is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AVEO Oncology

AVEO Oncology (NASDAQ: AVEO) is a cancer therapeutics company committed to discovering and developing targeted therapies designed to provide substantial impact in patients` lives with clear unmet medical needs. AVEO`s proprietary Human Response PlatformTM provides the company unique insights into cancer biology and is being leveraged in the discovery and clinical development of its cancer therapeutics.